Ellman

Healthcare Relocation Lump Sum Amounts Just Aren’t Cutting It - UrbanBound

Retrieved on: 
Wednesday, April 19, 2023
Supply Chain Management, Technology, Professional Services, Other Health, Health, General Health, Labor, Retail, Software, Public Policy, Government, Human Resources, Workforce, Organization, Entrepreneurship, Ellman, Nursing, Life insurance, Health care

Recruiting out of area healthcare professionals and providing lump sum relocation benefits is now a core part of healthcare organizations’ hiring strategy; yet, this provides little to no support or resources to relocating staff.

Key Points: 
  • Recruiting out of area healthcare professionals and providing lump sum relocation benefits is now a core part of healthcare organizations’ hiring strategy; yet, this provides little to no support or resources to relocating staff.
  • In the Healthcare industry, relocation lump sums (or cash stipends) for early career or non-exempt positions tend to average between $5,000 and $7,500 and the amounts have not, and are not, expected to rise as most healthcare systems are focused on keeping costs low.
  • “It’s extremely challenging to move cross-country for the amount that most Healthcare systems are paying,” said Jeff Ellman, Co-Founder of UrbanBound .
  • “We have seen instances where the negotiated supplier incentives have doubled and even tripled the value of the lump sum,” said Ellman.

Workforce Challenges: The #1 Concern for Health Systems for Second Year In a Row - UrbanBound

Retrieved on: 
Monday, February 13, 2023
Soccer, Professional Services, Health, Sports, Practice Management, Other Health, Human Resources, Caregiver, Organization, ROI, Frustration, Entrepreneurship, Ellman, Failure, Consultant, American College, COVID-19, Nursing

This is the second year in a row that these problems have been found as the top concern.

Key Points: 
  • This is the second year in a row that these problems have been found as the top concern.
  • It’s no surprise, considering the staffing scarcity, team burnout, retirements, and caregivers leaving the healthcare industry all together as a result of COVID-19.
  • Health systems are also having to deal with the reality that top talent is not necessarily in their backyard, and often requires candidates to relocate.
  • “When a health system provides only a lump sum disbursement they are fundamentally setting their staff up for failure.

Certis Oncology Releases New Cancer Model Database, BarneyOI™

Retrieved on: 
Wednesday, October 5, 2022
Software, Research, Professional Services, Pharmaceutical, Oncology, Data Management, Technology, Artificial Intelligence, Data Analytics, Science, Biotechnology, Health, Gene expression, Parent, Ellman, Database, PDX, Multimedia, Cancer, Medical imaging

Certis Oncology Solutions, a life science technology company, announced today the release of its new cancer model database, BarneyOI.

Key Points: 
  • Certis Oncology Solutions, a life science technology company, announced today the release of its new cancer model database, BarneyOI.
  • This proprietary, online repository houses deep molecular characterization data for Certis expanding bank of patient-derived xenograft (PDX) tumor models and cancer cell lines.
  • An industry-leading cancer model database is a natural complement to the worlds most clinically relevant, richly characterized cancer models.
  • About Certis Oncology Solutions: Certis Oncology Solutions is a life science technology company committed to realizing the promise of precision oncology.

Scientists Create Non-Psychedelic Compound with Same Anti-depressant Effect

Retrieved on: 
Wednesday, September 28, 2022
Mental Health, Research, Other Natural Resources, Other Health, Alternative Medicine, Health, Other Science, Science, Natural Resources, Tao, Selective serotonin reuptake inhibitor, National, Depression, Human, THP, LSD, DARPA, Patient, UNC, 5-HT2A, R-69, Anxiety, Research, Hallucination, Psychiatry, Eugene Higgins, Mouse, Serotonin, Doctor of Philosophy, DMT, Â, UCSF, Duke, Ketamine, Michael Hooker, FDA, MD, UNC School of Medicine, University of North Carolina at Chapel Hill, Stanford University, AstraZeneca, Permeability, Tony Hawk's Pro Skater 1 + 2, Department, Mount Sinai, Brain, Zehnder Confair, Psilocybin, Esketamine, Ellman, Neurochemistry, Defense, University of California, San Francisco, Protein, Cell, N,N-Dimethyltryptamine, Substance abuse, SSRI, Department of Defense Office of Inspector General, Multimedia, Neuron, Pharmaceutical industry, Yale University, Medicine, Pharmacology, Chemistry, Nature

Some advocates and scientists believe the actual psychedelic trip hallucinations and profound emotional experiences is what leads to long-lasting therapeutic effects.

Key Points: 
  • Some advocates and scientists believe the actual psychedelic trip hallucinations and profound emotional experiences is what leads to long-lasting therapeutic effects.
  • Other scientists speculate that if the trip could be eliminated from such drugs, then only the therapeutic effects might remain.
  • We were basically running a chemistry experiment to see if we could create a compound to activate 5-HT2A.
  • It would be a game changer to create a one-dose, long-acting therapy to help people with treatment-resistant depression and other conditions.

Cynosure Upgrades State-of-the-Art PicoSure® System with PicoSure® Pro Device

Retrieved on: 
Wednesday, June 1, 2022
Alexandrite, Cellulite, Collagen, Chrysoberyl, United Kingdom, Elastin, Pigment, Beauty, Exocrine gland, Pressure, Ellman, Ohta, Lens, Hori, Dubilier, Pain, Dermatology, Hair removal, Melasma, Nail, FDA, Patient, Elective surgery, RF, Board, Women's health, Nevus, Invention, Acne, World, Medical device, Cynosure

WESTFORD, Mass. , June 1, 2022 /PRNewswire/ -- Today Cynosure announced the launch of the PicoSure® Pro device, the latest upgrade to the company's best-in-class PicoSure system. The first and only FDA-cleared 755nm picosecond laser on the market, the PicoSure Pro device uniquely delivers energy in a trillionth of a second, utilizing pressure instead of heat to provide safe and effective treatments for unwanted pigmentation and skin revitalization for all skin types.

Key Points: 
  • The World's First and Only 755nm Picosecond Laser FDA-cleared to Treat Melasma Pigment, nevus of Ota and Hori's nevus
    WESTFORD, Mass., June 1, 2022 /PRNewswire/ -- Today Cynosure announced the launch of the PicoSure Pro device, the latest upgrade to the company's best-in-class PicoSure system.
  • The PicoSure Pro device's advanced Platinum Focus lens array is used to increase collagen and elastin to help combat wrinkles, acne scars and pores.
  • "With the PicoSure Pro device, providers can achieve comparable treatment results to more aggressive lasers with less pain and no downtime, making it a true one-and-done device for a myriad of patient needs."
  • The PicoSure Pro device is commercially available in the U.S. To learn more about the PicoSure Pro device, please visit www.cynosure.com/picosure .

Cynosure Launches PicoSure® Pro at AMWC: The World's First and Only 755nm FDA-cleared Laser For Treatment of Melasma Pigment

Retrieved on: 
Thursday, March 31, 2022
Alexandrite, Ohta, Congress, Invention, United Kingdom, Cellulite, Flat lens, Nevus, Patient, Hair removal, Elective surgery, Nail, Pressure, Fairmont Hotel, Hori, Fairmont Hotels and Resorts, RF, Elastin, Lens, Chrysoberyl, Dermatology, Women's health, Pigment, Ellman, FDA, Acne, Exocrine gland, Collagen, Pharmaceutical industry, Cosmetics, Tourism, Cynosure

CHISWICK, England, March 31, 2022 /PRNewswire/ -- Cynosure are launching the PicoSure® Pro system at the AMWC Congress in Monaco this weekend, and will be hosting a standalone launch symposium, led by renowned international expert Dr Christine Dierickx, who will present on this latest upgrade to the best-in-class PicoSure system. PicoSure® Pro is the first and only FDA-cleared 755nm picosecond laser on the market, and uniquely delivers energy in a trillionth of a second, utilising pressure instead of heat to provide safe and effective treatments for unwanted pigmentation and skin revitalisation of all skin types.

Key Points: 
  • The AMWC congress will see Cynosure unveil this industry-leading technology at an expert-led symposium focusing on "The Power of PicoSure Pro" and the data behind the FDA-approval for the 755nm treatment wavelength.
  • Leading laser expert Dr Dianne Quibell will also be presenting the PicoSure Pro and detail her clinical experience using PicoSure technology, alongside other energy devices in the Cynosure portfolio, including Potenza.
  • "As inventors of picosecond aesthetic laser technology, we are constantly challenging ourselves to continually drive innovation forward.
  • With the addition of the Flat Lens, PicoSure Pro is now also the first and only picosecond laser FDA-cleared for the treatment of melasma pigment and other hyperpigmentation issues such as nevus of Ota and Hori's nevus.

Certis Oncology Prevails in Spurious Lawsuit, Plaintiff Ordered to Pay Compensatory Damages

Retrieved on: 
Tuesday, December 21, 2021
Science, Legal, Biotechnology, Research, Pharmaceutical, Oncology, Health, Professional Services, Ellman, News, Judgement, Ownership, Anticarcinogen, Drug development, Risk, Fraud, Cancer, Superior court, People v. Superior Court (Romero), Patient, Science, Online gambling, Pharmaceutical industry, Certis Group

The court awarded Certis, the cross-complainant, compensatory damages of $625,000 plus another $168,400 related to a February 26, 2021, adjudication of a separate breach-of-contract claim.

Key Points: 
  • The court awarded Certis, the cross-complainant, compensatory damages of $625,000 plus another $168,400 related to a February 26, 2021, adjudication of a separate breach-of-contract claim.
  • Dr. Hoffmans claims were baseless and false, and the courtsonce againhave ruled accordingly, said Certis CEO, Peter Ellman.
  • The courts decision states, Dr. Hoffman has done all in his power to damage the reputation of Certis bycontinuing to post spurious disparaging comments on his AntiCancer website.
  • Following amendment of those complaints, AntiCancers claims were again dismissed in federal court and AntiCancer was ordered to pay costs incurred by Certis.

Cynosure CEO Wins Coveted Aesthetic Industry Leadership Award

Retrieved on: 
Monday, November 22, 2021
Alexandrite, Pond, RF, Skin, Hair removal, The Hershey Company, CEO, Technology, Industry, Women's health, Awareness, Cellulite, Health, Rejuvenation, Human, Ellman, Education, Dermatology, AIA, United Kingdom, Cynosure, MII, Beauty, Food, Growth, YAG, Medical imaging, Health insurance

WESTFORD,Mass., Nov. 22, 2021 /PRNewswire/ --The Aesthetic Industry Association (AIA) has awarded Cynosure Chief Executive Officer Todd Tillemans, the coveted Aesthetic Industry Leadership Award, recognizing his pioneering leadership to support the long-term growth and sustainability of the aesthetic industry.

Key Points: 
  • WESTFORD,Mass., Nov. 22, 2021 /PRNewswire/ --The Aesthetic Industry Association (AIA) has awarded Cynosure Chief Executive Officer Todd Tillemans, the coveted Aesthetic Industry Leadership Award, recognizing his pioneering leadership to support the long-term growth and sustainability of the aesthetic industry.
  • "I am honored to accept the Aesthetic Industry Leadership Award from AIA," said Todd Tillemans, Chief Executive Officer at Cynosure.
  • The Aesthetic Industry Association (AIA) is the first and only member-driven organization dedicated to the long-term health, sustainability, and development of the $14 billion medical aesthetic industry.
  • The Aesthetic Industry Association (AIA) is the first and only member-driven organization dedicated to the long-term health, sustainability, and development of the $14 Billion medical aesthetic industry.

Cynosure Enters Men's Sexual Health with New ViaSure™ System

Retrieved on: 
Monday, November 1, 2021
Alexandrite, RF, Elasticity, Chrysoberyl, Penis, Health minister, Patient, Ellman, Elective surgery, United Kingdom, Cynosure, Cellulite, Hair removal, Man, Women's health, Sexual dysfunction, Dermatology, Blood, Medical imaging, Health insurance

The ViaSure treatment is a safe, effective, non-invasive alternative to traditional medication typically used to temporarily treat sexual performance issues.

Key Points: 
  • The ViaSure treatment is a safe, effective, non-invasive alternative to traditional medication typically used to temporarily treat sexual performance issues.
  • "Studies show that 50 percent of men over the age of 50 will experience sexual dysfunction," said Todd Tillemans, Chief Executive Officer at Cynosure."
  • The ViaSure system is the only men's sexual health device with proprietary SoftWave technology featuring an applicator with a unique design toensure optimal, consistent coverage and depth of shockwave energy.
  • "ViaSure has been a great addition to our treatment offering for men's sexual health," said Dr. Irwin Goldstein, San Diego Sexual Medicine.

Commercial UAV Expo 2021 Reconvenes In-Person, Exceeds Expectations

Retrieved on: 
Wednesday, September 15, 2021
Walker, CEO, Government, AVS, Solution, Mining, SPAR, Law enforcement, Bots, RAI Amsterdam, Time, Commercial, Fire department, Sustainable Energy Utility, Collaboration, Drone, Adorama, UAS, General counsel, EVS, News, UTM, Ellman, AEE, Forestry, American Fuel and Petrochemical Manufacturers, FAA, Construction, Investment, Indian Institute of Surveying & Mapping, Diversified Communications, Ministry of Land, Infrastructure, Transport and Tourism, Chula Vista Police Department, NAS, Emergency service, Energy, Safety, Mirage, RAI Amsterdam Convention Centre, AAM, Seeker, AFPM, Robotics, AEC, Publication, Technology, Human, Transport, Industry, Caesars Forum, Partnership, Last mile, ROI, Public relations, Management, Video game

LAS VEGAS, Sept. 15, 2021 /PRNewswire-PRWeb/ -- Commercial drone exhibitors and attendees gathered last week for Commercial UAV Expo Americas 2021, held September 7-9, 2021 at the Mirage in Las Vegas.

Key Points: 
  • LAS VEGAS, Sept. 15, 2021 /PRNewswire-PRWeb/ -- Commercial drone exhibitors and attendees gathered last week for Commercial UAV Expo Americas 2021, held September 7-9, 2021 at the Mirage in Las Vegas.
  • At least a dozen new products were introduced at Commercial UAV Expo Americas this year, including making it a true hub for innovation.
  • Commercial UAV Expo Americas, presented by Commercial UAV News, is an international conference and expo exclusively focused on commercial UAS integration and operation covering industries including Construction; Energy & Utilities; Forestry & Agriculture; Infrastructure & Transportation; Mining & Aggregates; Public Safety & Emergency Services; Security; and Surveying & Mapping.
  • Commercial UAV Expo Americas is produced by Diversified Communications' technology portfolio which also includes Commercial UAV Expo Europe; Commercial UAV News; Geo Week comprised of the International Lidar Mapping Forum, SPAR 3D Expo & Conference, AEC Next Technology Expo & Conference; Geo Week ENewsletter, SPAR 3D ENewsletter, AEC Next ENewsletter.